The purpose of this study is to measure the safety of the investigational imaging agent, 18F-Var3 and to determine if it is helpful in providing information about how tumor tissues behave.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
6
Participants will undergo up to 5 serial F-Var3 PET/CT scans within 25 minutes of the injection of 18F-Var3, 30, 60, 120 and 240 minutes after injection of the 18FVar3.
Collection of blood for research tests before the injection, 30, 60, 120 and 240 min after the injection.
Memorial Sloan-Kettering Cancer Center
New York, New York, United States
Incidence of Treatment-Emergent Adverse Events as assessed by CTCAE v5.0
The safety of patients will be evaluated using Common Terminology Criteria for Adverse Events (CTCAE) v5.0. Grade 1 and grade 2 toxicities are considered safe.
Time frame: 30 days after completion of study treatment and assessments
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.